Sera Prognostics PE Ratio 2021-2025 | SERA
Current and historical p/e ratio for Sera Prognostics (SERA) from 2021 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Sera Prognostics PE ratio as of August 26, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Sera Prognostics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-26 | 3.05 | 0.00 | |
| 2025-06-30 | 2.77 | $-0.85 | 0.00 |
| 2025-03-31 | 3.68 | $-0.94 | 0.00 |
| 2024-12-31 | 8.14 | $-0.99 | 0.00 |
| 2024-09-30 | 7.80 | $-0.99 | 0.00 |
| 2024-06-30 | 5.92 | $-0.98 | 0.00 |
| 2024-03-31 | 9.10 | $-1.07 | 0.00 |
| 2023-12-31 | 5.98 | $-1.16 | 0.00 |
| 2023-09-30 | 1.86 | $-1.22 | 0.00 |
| 2023-06-30 | 3.30 | $-1.34 | 0.00 |
| 2023-03-31 | 3.83 | $-1.37 | 0.00 |
| 2022-12-31 | 1.26 | $-1.43 | 0.00 |
| 2022-09-30 | 1.60 | $-1.53 | 0.00 |
| 2022-06-30 | 1.64 | $-1.57 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.099B | $0.000B |
| Sera Prognostics Inc. is a women's health diagnostics company. It focused on improving maternal and neonatal health by providing pregnancy biomarker information to doctors and patients. Sera Prognostics Inc. is based in SALT LAKE CITY. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.745B | 27.59 |
| CVS Health (CVS) | United States | $90.318B | 11.23 |
| Elevance Health (ELV) | United States | $70.706B | 9.51 |
| Cencora (COR) | United States | $55.895B | 18.61 |
| DiDi Global (DIDIY) | China | $26.780B | 28.45 |
| Labcorp Holdings (LH) | United States | $22.945B | 18.24 |
| Natera (NTRA) | United States | $22.299B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.987B | 0.00 |
| ICON (ICLR) | Ireland | $13.870B | 13.35 |
| Medpace Holdings (MEDP) | United States | $13.114B | 34.71 |
| CochLear (CHEOY) | Australia | $12.814B | 0.00 |
| Solventum (SOLV) | United States | $12.614B | 13.01 |
| Viatris (VTRS) | United States | $12.300B | 4.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.822B | 0.00 |
| Revvity (RVTY) | United States | $10.695B | 18.84 |
| Avantor (AVTR) | United States | $9.006B | 13.21 |
| Charles River Laboratories (CRL) | United States | $8.077B | 15.32 |
| Sonic Healthcare (SKHHY) | Australia | $7.700B | 0.00 |
| HealthEquity (HQY) | United States | $7.560B | 33.11 |
| Bausch + Lomb (BLCO) | Canada | $5.143B | 34.60 |
| Sotera Health (SHC) | United States | $4.656B | 26.02 |
| BrightSpring Health Services (BTSG) | United States | $4.266B | 32.54 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.501B | 80.18 |
| KindlyMD (NAKA) | United States | $3.449B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $3.085B | 0.00 |
| Concentras Parent (CON) | United States | $3.002B | 19.04 |
| Surgery Partners (SGRY) | United States | $2.954B | 37.16 |
| Organon (OGN) | United States | $2.355B | 2.57 |
| Premier (PINC) | United States | $2.116B | 19.62 |
| Progyny (PGNY) | United States | $1.990B | 42.07 |
| Ardent Health (ARDT) | United States | $1.816B | 7.01 |
| PACS (PACS) | United States | $1.797B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.486B | 9.92 |
| GoodRx Holdings (GDRX) | United States | $1.477B | 25.00 |
| Teladoc Health (TDOC) | United States | $1.355B | 0.00 |
| Omada Health (OMDA) | $1.209B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.178B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.834B | 4.88 |
| AMN Healthcare Services Inc (AMN) | United States | $0.793B | 9.81 |
| CareDx (CDNA) | United States | $0.679B | 12.50 |
| Performant Healthcare (PHLT) | United States | $0.600B | 0.00 |
| Agilon Health (AGL) | United States | $0.572B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.519B | 89.00 |
| Nutex Health (NUTX) | United States | $0.497B | 7.53 |
| InnovAge Holding (INNV) | United States | $0.496B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.491B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 6.91 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.439B | 0.00 |
| SBC Medicals (SBC) | United States | $0.429B | 9.39 |
| Enhabit (EHAB) | United States | $0.409B | 26.90 |
| So-Young (SY) | China | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.324B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.266B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.229B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.146B | 0.00 |
| Biodesix (BDSX) | United States | $0.072B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.025B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |